Stock & Company Details
BridgeBio Pharma Inc $BBIO
Price:
46,691,331
196M
$15B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
-9.40
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
BBIO technical indicators
Latest BridgeBio Pharma Inc (BBIO) technical indicators as of 2026-06-30: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
68.31 8.9%
MACD:
0.95 71.5%
SMA 50:
$68.77 0.1%
SMA 200:
$68.16 0.2%
EMA 20:
$69.07 0.8%
Bollinger Bands:
72.62 / 63.66
Stochastic:
82.84 8.3%
ADX 14:
14.12 16.2%
ATR 14:
2.70 0.5%
CCI 20:
233.12 8.3%
OBV:
138.34M 2.5%
ROC 12:
10.26% 50.3%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy. The company focus on genetic diseases because they exist at the intersection of high unmet patient need and tractable biology.
Finance Bot
Ask your questions
Start by typing a question below.
